Literature DB >> 6429730

Family physicians' beliefs about screening for colorectal cancer using the stool guaiac slide test.

K M Cummings, C R Jaen, D P Funch.   

Abstract

The stool guaiac slide test (SGST) is a relatively recent innovation in screening for colorectal cancer. The test detects occult blood in the stool that may indicate the presence of cancer. In recent years, the SGST has been widely promoted as a screening test to aid in the detection of colorectal cancer. However, data from public and mass screening programs indicate that many people are unaware of the test and that few have actually taken it. The findings from these studies suggest that many physicians may not be using the test in their medical practices. The literature on diffusion theory suggests that acceptance of an innovation is influenced by the potential adopter's perception of the innovation's relative advantages over those of the ideas it supersedes, its perceived complexity, and its compatibility with the existing values and practices of the receiver. This research examined these factors as they relate to use of the SGST among a sample of 131 family physicians in New York State. Eighty-two percent of these physicians reported that they provide guaiac slides to at least some of their patients to collect stool specimens at home. The test was reportedly more commonly used for older patients than for younger ones. The physicians' beliefs about the relative effectiveness of the test in detecting early-stage colorectal cancer, compared with the effectiveness of alternative screening tests, and their perceptions about patients' willingness and ability to do the test at home were found to be important factors distinguishing between physicians who said they used the test and physicians who did not. The findings from this study suggest that future efforts aimed at promoting the use o1 theSGST among primary care physicians should emphasize the relative merits of the test in comparison with those of alternative screening procedures, especially with regard to its effectiveness in detecting early stage cancers, its simplicity, and its acceptance by patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6429730      PMCID: PMC1424584     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  16 in total

1.  Quantitative determination of gastrointestinal bleeding using Cr51-labeled red blood cells.

Authors:  G IZAK; Y STEIN; A KARSHAI
Journal:  Am J Dig Dis       Date:  1960-01

2.  Sensitivity and reproducibility of chemical tests for fecal occult blood with an emphasis on false-positive reactions.

Authors:  J D Ostrow; C A Mulvaney; J R Hansell; R S Rhodes
Journal:  Am J Dig Dis       Date:  1973-11

3.  Mass screening for colorectal cancer.

Authors:  J B Hastings
Journal:  Am J Surg       Date:  1974-02       Impact factor: 2.565

4.  A progress report. Detection of colorectal cancer using guaiac slides.

Authors:  D H Greegor
Journal:  CA Cancer J Clin       Date:  1972 Nov-Dec       Impact factor: 508.702

5.  Screening in family medicine: the current situation.

Authors:  W W Rosser
Journal:  J Fam Pract       Date:  1978-03       Impact factor: 0.493

6.  Enhancing the effectiveness of media messages promoting regular breast self-examination: messages based on innovation adoption principles.

Authors:  H L Howe
Journal:  Public Health Rep       Date:  1981 Mar-Apr       Impact factor: 2.792

7.  Patient compliance with self-directed Hemoccult testing.

Authors:  G R Morrow; J Way; A C Hoagland; R Cooper
Journal:  Prev Med       Date:  1982-09       Impact factor: 4.018

8.  Diagnosis of large-bowel cancer in the asymptomatic patient.

Authors:  D H Greegor
Journal:  JAMA       Date:  1967-09-18       Impact factor: 56.272

9.  A mass screening program for colorectal cancer using chemical testing for occult blood in the stool.

Authors:  D P Winchester; J H Shull; E F Scanlon; J V Murrell; C Smeltzer; P Vrba; M Iden; D H Streelman; R Magpayo; J W Dow; J Sylvester
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

10.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

View more
  2 in total

1.  Occult blood screening.

Authors: 
Journal:  CMAJ       Date:  1985-12-15       Impact factor: 8.262

2.  Physicians' beliefs about effectiveness of cancer screening tests: a national survey of family physicians, general internists, and obstetrician-gynecologists.

Authors:  Jacqueline W Miller; Laura-Mae Baldwin; Barbara Matthews; Katrina F Trivers; C Holly Andrilla; Denise Lishner; Barbara A Goff
Journal:  Prev Med       Date:  2014-07-17       Impact factor: 4.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.